跳至主要内容
临床试验/NCT05426213
NCT05426213撤回不适用

A Real-World Study to Evaluate the Effectiveness and Safety of Robot-Assisted Bronchoscopy in Chinese Patients With Lung Lesions

Auris Health, Inc.0 个研究点开始时间: 2022年7月12日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Navigation Success Rate

研究概览

简要总结

Robot-assisted bronchoscopy biopsy procedure will be conducted for all eligible subjects under general anesthesia status by trained investigators in hospital.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Capable and willing to give informed consent
  • Acceptable candidate for an elective, non-emergency bronchoscopic procedure
  • Lung lesions suspected of malignancy, between 8-50 millimeters (mm) in diameter size identified on thin slice (0.9-1.25 mm) computed tomography (CT) scan within 14 days, requiring bronchoscopic biopsy for diagnosis
  • No more than 1 lung lesion will be targeted for robot-assisted bronchoscopy biopsy

排除标准

  • Pre-Operative
  • Participants with pure ground-glass opacity lesions on pre-procedure chest CT
  • Participants with the target lesion having endobronchial involvement seen on chest CT
  • Medical contraindications to bronchoscopy and/or anesthesia as assessed by the investigator (such as severe cardiac arrhythmias, severe hypertension, severe cardiopulmonary dysfunction, myocardial infarction, unstable angina pectoris et cetera [etc]) precluding safe bronchoscopic procedure

结局指标

主要结局

Navigation Success Rate

时间窗: Intraoperative

Navigation success rate is defined as the percentage of successful navigation to the targeted lung lesion (lesion localization) as confirmed by radial probe endobronchial ultrasound (R-EBUS) imaging through Monarch Platform during bronchoscopy procedure.

次要结局

  • Total Procedure Time(Intraoperative)
  • Time to R-EBUS Confirmation(Intraoperative)
  • Number of Conversion to Conventional Bronchoscopic Procedure(Intraoperative)
  • Time to the Tissue Acquisition(Intraoperative)
  • Number of Participants with Pneumothorax Requiring Intervention(Up to 7 days post procedure)
  • Number of Participants with Device or Procedure Related Respiratory Failure(Up to 7 days post procedure)
  • Number of Participants with Device or Procedure Related Bleeding Requiring Medical Intervention(Up to 7 days post procedure)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验